Concepedia

Mikel Etchegaray

ME

Statistics

Publications

3

Citations

115

H-Index

3

Active since

2007

Affiliations

The University of Texas Health Science Center at Houston(Current)

The University of Texas MD Anderson Cancer Center

Mikel Etchegaray is an author at The University of Texas Health Science Center at Houston specializing in immune-related adverse events, immunotherapy, and checkpoint inhibitor therapy.

Publications per year

2007–2020

3

Publications

3

The Terrible Triad of Checkpoint Inhibition: A Case Report of Myasthenia Gravis, Myocarditis, and Myositis Induced by Cemiplimab in a Patient with Metastatic Cutaneous Squamous Cell Carcinoma

Nikeshan Jeyakumar, Mikel Etchegaray, Jason T. Henry et al. · Case Reports in Immunology · 2020 · 51 citations · Full text

, , +17

Impairments in timing, temporal memory, and reversal learning linked to neurotoxic regimens of methamphetamine intoxication

Ruey‐Kuang Cheng, Mikel Etchegaray, Warren H. Meck · Brain Research · 2007 · 45 citations

, , +17

Role of Infliximab in Immune Checkpoint Inhibitor-Induced Pneumonitis

Kathryn A. Lai, Ajay Sheshadri, Andres M. Adrianza et al. · Journal of Immunotherapy and Precision Oncology · 2020 · 19 citations · Full text

, , +15

1–3 of 3